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The introduction and expression of a foreign gene provide
a powerful tool for investigating functions and regulation
of a gene of interest; however, keratinocytes have a major
drawback in that foreign genes are hardly transfected by
conventional methods and stable transformants are most
difficult to establish in normal keratinocytes with a limited
short life span. To overcome these problems, we used an
adenovirus vector, Ax, developed by Saito et al, which
yields desired recombinant viruses at an efficiency about
100-fold that of conventional methods, and by which
genes are expressed at a high level under the control of
TRANSFER OF GENES INTO CELLS
Transfer of foreign genes into cells and their expression are a powerful
tool in elucidating a function(s) of genes of interest; however, eukaryotic
cells have natural defense mechanisms against invasion of foreign DNA
except for infection by viruses. Otherwise, cells are mutated easily,
thus being unable to survive and preserve the species. Therefore, a
breakthrough in technology was needed for transfer of foreign genes
into eukaryotic cells.
In 1975, Alex Van der Eb and his associates demonstrated that
cultured mammalian cells can be transformed with precipitates of
calcium phosphate and purified SV40 or adenovirus DNA (Abrahams
and Van der Eb, 1975). This simple technique is based on phagocytosis
of cells engulfing precipitates, although the precise mechanisms by
which a foreign gene is integrated into the cell genome are still
unknown. Wigler and Axel improved this technique by the use of a
selectable marker gene along with the foreign gene, making it possible
to readily identify cells that have incorporated and expressed them
(Wigler et al, 1977). ‘‘Transfection’’, a new term, has been adopted for
this technical breakthrough. Nowadays, a number of techniques for
transfection have been established using chemical, physical, and viral
means (Table I). Transfer of genes into keratinocytes was reviewed
by Fenjves (1994).
Viruses can be defined as a device introducing foreign genes, i.e.,
the viral genome into cells. For introduction of a gene of interest, viral
vectors have been developed by modification of viral genomes in the
form of replication defective. The most widely used viral vectors are
those based on retroviruses, adenoviruses, and baculoviruses (Table I).
Retrovirus and adnovirus vectors are widely used for gene therapy as
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a composite CAG promoter. We established Ax vectors
carrying various isoforms of protein kinase C (PKC).
Using these vectors, we found that the η and d isoforms
of PKC, but not the a and ζ isoforms, mediate terminal
differentiation in normal human keratinocytes. These
Ax-vectors are also applicable to organ culture of mouse
embryos. Advantages and disadvantages of adenovirus
vectors and their use for keratinocyte biology are
reviewed. Key words: adenovirus/keratinocytes/protein kinase
C/differentiation. Journal of Investigative Dermatology Sympo-
sium Proceedings 4:153–157, 1999
well as experimental purposes, whereas an insect baculovirus has a
great advantage in production of a large amount of proteins.
ADENOVIRUS VECTORS
Studies with keratinocytes have been hampered by the difficulty of
introducing foreign genes as the transfection efficiency by conventional
methods is very low (Jiang et al, 1991), and the use of Ca21 often
induces terminal differentiation (Yuspa et al, 1982). Furthermore, the
short life span of normal keratinocytes does not allow isolation of stable
transformants.
To overcome these problems, adenovirus vectors have been used
recently in transferring genes into keratinocytes. Adenoviruses have a
natural tropism for respiratory and oral epithelial cells with a nature
like that of keratinocytes, although they exhibit a broad range of host
specificity. Replication-defective adenoviruses have been developed as
a vector for therapeutic as well as experimental purposes. There
are advantages and disadvantages of adenovirus vectors over other
transfection methods or virus vectors. These include the following:
1 Adenoviruses can infect almost all cell types with high efficiency,
though the efficiency is lower in blood borne cells, e.g., myeloid cells
or macrophages.
2 A gene introduced by an adenovirus vector is expressed at high
level within a short time (6–12 h) after infection, and lasts at least for
48 h or more depending on dilution through cell division.
3 Isolation of clones expressing the introduced gene is not necessary.
4 Expression levels can be controlled by the dose of the virus, i.e.,
multiplicity of infection (m.o.i.), allowing study of the gene dosage–
response relationship.
5 Adenovirus vectors are particularly useful in introducing genes into
nonreplicating cells or cells with a short life span, whereas retroviruses
are applicable only to replicating cells.
6 By the same token, genes causing growth arrest or apoptosis can
be introduced by adenovirus vectors.
7 No modification of the host genome structure by integration of a
foreign gene occurs because of its presence as an episome.
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Table I. Techniques for introduction of foreign genes into
mammalian cells
Chemical introduction
Calcium phosphate
Lipofection
Mechanical introduction
Electroporation
Microinjection
Viral introduction
Retrovirus
Adenovirus
Baculovirus
8 Using the cre-loxP system, gene expression can be controlled.
On the other hand, adenovirus vectors have the following disad-
vantages:
1 Expertise is needed for preparation of virus vectors, as they take at
least 2 mo for construction.
2 Adenovirus vectors are diluted through cell division. This transient
expression is one of the main drawbacks to the adenovirus system.
3 The virus itself shows toxicity to some extent, so that inclusion of
a control vector, e.g., lacZ, is recommended.
4 Immunocompetent cells may produce an antibody against the virus.
We have been using an adenovirus vector, Ax, developed by Saito
and his associates (Kanegae et al, 1994, 1995; Miyake et al, 1996). The
cosmid cassette (pAxCAwt) has a nearly full length adenovirus 5
genome but lacks E1A, E1B, and E3 regions, being replication
defective. It contains a composite CAG promoter, consisting of a
cytomegalovirus immediate-early enhancer, chicken β-actin promoter,
and rabbit β-globin polyadenylation signal, which strongly induces
expression of inserted DNA (Niwa et al, 1991). A gene of interest is
inserted into the cosmid cassette, which is then cotransfected into
human embryonic kidney 293 cells together with adenovirus DNA-
terminal protein complex (TPC). In 293 cells that express E1A and
E1B regions, recombination occurs between the cosmid cassette and
adenovirus DNA-TPC, yielding the desired recombinant virus at an
efficiency 100-fold that of conventional methods. Such a high efficiency
is mainly due to the use of the adenovirus DNA-TPC instead of
proteinased DNA. Furthermore, the presence of longer homologous
regions increases the efficiency of homologous recombination. Regen-
eration of replication competent viruses is avoided due to the presence
of multiple EcoT221 sites.
ADENOVIRUS-MEDIATED INTRODUCTION OF PROTEIN
KINASE C ISOFORMS INTO NORMAL HUMAN
KERATINOCYTES
Protein kinase C (PKC) exists as a family composed of at least 10
isoforms. The PKC isoforms are classified into three major groups
based on their structures and activation mechanisms (Nishizuka, 1988),
i.e., phosphatidylserine (PS), diacylglycerol, and Ca21-dependent con-
ventional PKC (α, βI, βII, and γ isoforms); Ca21-independent novel
PKC (δ, ε, η, and θ isoforms); and diacylglycerol and Ca21-independent
atypical PKC (ζ and λ/ι isoforms).
Of these PKC isoforms, we isolated the η and θ isoforms from a
cDNA library of mouse skin (Osada et al, 1990, 1992). The η isoform
has a unique tissue distribution; it is predominantly expressed in
epithelial tissues, including skin, tongue, esophagus, stomach, intestine,
trachea, and bronchus (Osada et al, 1990, 1993). In situ hybridization
and immunohistochemical staining demonstrated that the η isoform is
highly expressed in differentiating and differentiated epithelial cells
(Osada et al, 1993). Furthermore, cholesterol sulfate, an abundant lipid
in the granular layer, activates the η and other isoforms (Ikuta et al,
1994; Denning et al, 1995). It has been shown that cholesterol sulfate
induces differentiation of mouse keratinocytes in vitro and in vivo
(Denning et al, 1995; Chida et al, 1995) and activates transcription of
transglutaminase 1 (TGase 1) in normal human keratinocytes (Kawabe
et al, 1998). It also inhibits tumor promotion in mouse skin carcinogen-
esis without inhibition of the induction of ornithine decarboxylase by
a tumor promoter (Chida et al, 1995).
Figure 1. Autophosphorylation activity of wild and dominant negative
PKC isoforms. Top: Autophosphorylation of the η and δ isoforms and
their dominant-negative mutants (DN) infected into COS1 cells. Note that
phosphorylated bands with 80 kDa (η) and 78 kDa (δ) are seen in the cells
infected with wild η and δ isoforms but not in those with dominant-negative
mutants. Bottom: Immunoblotting demonstrates the presence of the gene
products of both wild-type and dominant negative η and δ isoforms (Ohba
et al, 1998 and unpublished data).
To assess possible roles of PKC isoforms in regulation of growth
and differentiation of keratinocytes, we constructed Ax vectors carrying
the α, δ, η, and ζ isoforms of PKC (Ohba et al, 1998). We also
prepared a dominant-negative mutant of the η and δ isoforms, in
which the lysine residue at the ATP binding site is replaced by alanine
(Ohno et al, 1990), abrogating the autophosphorylation activity (Fig 1).
We found that PKC isoforms introduced by Ax were highly
expressed in normal human keratinocytes at the levels of mRNA and
protein. The expression appeared within 12 h after infection, reaching
the maximal level at 24 h and maintaining a high level at least up to
72 h. The kinase activity of the η isoform introduced by Ax-PKCη
was demonstrated by autophosphorylation of the immunoprecipitated
material from COS1 cells. A partially purified fraction of the infected
keratinocytes showed much higher activity than the Ax-lacZ control,
which was further stimulated in the presence of PKC activators, i.e.,
PS plus phorbol ester or cholesterol sulfate (Fig 2). These results
indicate that gene transfer by the Ax adenovirus vector makes it
possible to study possible functions of PKC isoforms in growth and
differentiation of keratinocytes.
We found that overexpression of the η isoform inhibited the growth
of keratinocytes of humans and mice in a dose (m.o.i.)-dependent
manner, leading to G1 arrest. The PKCη-overexpressing cells became
enlarged and flattened, showing squamous cell phenotypes. Expression
and activity of TGase 1, a key enzyme of squamous cell differentiation,
were induced in the PKCη-overexpressing cells in dose (m.o.i.)- and
time-dependent manners. The inhibition of growth and the induction
of TGase 1 activity were found only in the cells that expressed the η
isoform endogenously, i.e., in human and mouse keratinocytes but not
in human and mouse fibroblasts or COS 1 cells. A dominant-negative
η isoform counteracted the induction of TGase 1 by differentiation
inducers such as a phorbol ester, 1α,25-dihydroxyvitamin D3 and a
high concentration of Ca21 (Fig 3). Among the isoforms examined,
the δ isoform also inhibited the growth of keratinocytes and induced
TGase 1, but the α and ζ isoforms did not. These findings indicate
that η and δ isoforms of PKC are intimately involved in squamous
cell differentiation.
INTRODUCTION OF A GENE INTO AN ORGAN
CULTURE OF DEVELOPING MOUSE SKIN
Induction of differentiation by the η isoform of PKC was further
examined using an organ-culture system of developing mouse skin, in
which the skin tissue isolated from 12.5- or 13.5-d postcoitus embryos
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Figure 2. Kinase activities of the COS1 cells infected with Ax carrying
the lacZ, η, a, d, and ζ isoforms. Note that the kinase activity of the η-
overexpressing cells was stimulated by phorbol ester plus PS and cholesterol
sulfate (Ohba et al, 1998).
Figure 3. Suppression by dominant-negative η isoform of differentiation
induced known inducers, e.g., 0.2 mM Ca21 (Ca21), 12 nM 1a,25-
dihydrovitamin D3 (VitD3), and 12-O-tetradecanoylphorbolester
(TPA). Differentiation is assayed by activity of TGase 1. Dark bars, controls
treated with Ax-lacZ; open bars, those treated with the dominant-negative η
isoform (Ohba et al, 1998).
develops in a manner that is histologically and temporally similar to
the process in vivo (Kashiwagi et al, 1997). When 13.5-d embryo skin
was infected with Ax-lacZ, the whole epidermal layer was stained blue
24 h after the infection, but this decreased with further incubation for
2 d mainly due to a dilution effect through cell division of epidermal
keratinocytes (Fig 4) (and cover of this issue).
A similar time course of the expression was observed when Ax-
PKCη was applied under the same conditions. By immunoblotting, a
distinct band corresponding to the η isoform was observed on day 1
but decreased on day 2 and disappeared on day 3 (Fig 5). Histologically,
the Ax-PKCη infected cultures showed thicker cornified and granular
layers compared with the Ax-lacZ-infected control culture (Fig 6).
These results indicate that the η isoform of PKC mediates terminal
Figure 4. Introduction and expression of the Ax-lacZ in the organ
culture of mouse embryo skin. Ax-lacZ vector was infected to 13.5 dpc
embryo skin in organ culture for 24 h (B) and followed for 24 h (C) and 48 h
(D). (A) Non-infected control. (Kashiwagi et al, 1997).
differentiation of keratinocytes in the organ culture system, mimicking
embryo skin.
INDUCTION OF G1 ARREST BY ADENOVIRUS-
MEDIATED INTRODUCTION OF PKC ISOFORMS INTO
MOUSE KERATINOCYTES
To examine possible involvement of PKC-isoforms in cell cycle arrest,
Ax-PKC vectors were applied to synchronously growing BALB/MK-
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Figure 5. Expression of the infected η isoform in organ culture of
mouse skin. The cultures were infected with Ax-lacZ or Ax-PKCη for 24 h
(1D) and followed for 24 h (2D) and 48 h (3D), subjected to immunoblotting.
P, authentic PKCη.
Figure 6. Induction of differentiation in organ culture infected with
Ax-PKCη. Thicker cornified and granular layers are seen in the cultures
infected with Ax-PKCη for 24 h and followed for 48 h (B), compared with
the control culture infected with Ax-lacZ (A).
2 keratinocytes (Ishino et al, 1998). We found that the growth arrest
induced by a phorbol ester, a PKC agonist, was cell-cycle dependent,
being most evident at the G1/S boundary. This phorbol ester-induced
growth arrest was found to be augmented by infection with Ax-PKCη
and Ax-PKCδ but rescued by the dominant-negative or antisense Ax-
PKCη. These observations provide evidence that the η and δ isoforms
of PKC are involved in negative regulation of the cell cycle at the
G1/S boundary.
USE OF ADENOVIRUS VECTORS IN KERATINOCYTE
BIOLOGY
Because of their usefulness, adenovirus vectors have been used to study
keratinocyte biology in many laboratories. DiCunto et al (1998)
used a recombinant adenovirus to assess the biologic meaning of
p21cip1/WAF1 expression in differentiation of primary keratinocytes of
mice. The adenovirus constructs that they used were those expressing
an intact p21 protein, a p21 protein with a deletion of its COOH-
terminal and p16INK4a. A vector carrying lacZ was used as a control.
Using these viral vectors, the authors found that p21 inhibits the late
stage of differentiation independently of its function in cell cycle
control. A similar line of study in cell cycle and differentiation was
reported by Harvat et al (1998).
Herlitz-junctional epidermolysis bullosa is caused by homozygous
mutation of the laminin-5 gene generating a premature termination
codon. Gagnoux-Palacios et al (1996) found that reduced adherence
of laminin-5 deficient keratinocytes was rescued by introduction of
the wild-type gene using adenovirus and retrovirus vectors.
The skin has a potential for a variety of gene therapy applications
(see review by Greenhalgh et al, 1994). Feasibility of adenovirus-
mediated gene transfer to skin was demonstrated by Setoguchi et al
(1994) using human α1-antitrypsin and β-galactosidase genes. These
genes were introduced into murine keratinocytes in culture and
subjected to transplantation. Recipient mice expressed the products of
these genes for at least 14 d at a high level. In addition to these ex vivo
conditions, genes introduced by adenovirus vectors were found to be
expressed in skin and serum when injected subcutaneously.
In conclusion, adenovirus vector systems are useful in introducing
genes of interest into normal keratinocytes, allowing their expression
with high efficiency in infected cells.
This work was supported by a Grant-in-Aid from the Ministry of Education, Science,
Sports and Culture of Japan (#06281216).
REFERENCES
Abrahams PJ, Van der Eb AJ: In vitro transformation of rat and mouse cells by DNA from
simian virus 40. J Virol 16:206–209, 1975
Chida K, Murakami A, Tagawa T, Ikuta T, Kuroki T: Cholesterol sulfate, a second
messenger for the η isoform of protein kinase C, inhibits promotional phase in
mouse skin carcinogenesis. Cancer Res 55:4865–4869, 1995
Denning MF, Kazanietz MG, Blumberg PM, Yuspa SH: Cholesterol sulfate activates
multiple protein kinase C isoenzymes and induces granular cell differentiation in
cultured murine keratinocytes. Cell Growth Differ 6:1619–1626, 1995
DiCunto F, Topley G, Calautti E, Hsiao J, Ong L, Seth PK, Dotto GP: Inhibitory function
of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent
of cell cycle control. Science 280:1069–1072, 1998
Fenjves ES: Approaches to gene transfer in keratinocytes. J Invest Dermatol 103:70S–75S, 1994
Gagnoux-Palacios L, Vailly J, Durand-Clement M, Wagner E, Ortonne JP, Meneguzzi
G: Functional Re-expression of laminin-5 in laminin-gamma2-deficient human
keratinovytes modifies cell morphology, motility, and adhesion. J Biol Chem
271:18437–18444, 1996
Greenhalgh DA, Rothnagel J, Roop DR: Epidermis: an attractive target tissue for gene
therapy. J Invest Dermatol 103:63S–69S, 1994
Harvat BL, Wang A, Seth P, Jetten AM: Up-regulation of p27Kip1 p21WAF1/Cip1
and p16Ink4a is associated with, but not sufficient for, induction of squamous
differentiation. J Cell Sci 111:1185–1196, 1998
Ikuta T, Chida K, Tajima O, et al: Cholesterol sulfate, a novel activator for the η isoform
of protein kinase C. Cell Growth Differ 5:943–947, 1994
Ishino K, Ohba M, Kashiwagi M, Kawabe S, Chida K, Kuroki T: Phorbol ester-induced
G1 arrest in BALB/MK-2 mouse keratinocytes is mediated by δ and η isoforms of
protein kinase C. Jpn J Cancer Res 89:1126–1133, 1998
Jiang CK, Connolly D, Blumenberg M: Comparison of methods for transfection of human
epidermal keratinocytes. J Invest Dermatol 97:969–973, 1991
Kanegae Y, Makimura M, Saito I: A simple and efficient method for purification of
infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157–166, 1994
Kanegae Y, Lee G, Sato Y, et al: Efficient gene activation in mammalian cells by using
recombinant adenovirus expressing site-specific Cre recombinase. Nucl Acids Res
23:3816–3821, 1995
Kashiwagi M, Kuroki T, Huh NH: Specific inhibition of hair follicle formation by
epidermal growth factor in an organ culture of developing mouse skin. Dev Biol
189:22–32, 1997
Kawabe S, Ikuta T, Ohba M, Chida K, Ueda E, Yamanishi K, Kuroki T: Cholesterol sulfate
activates transcription of transglutaminase 1 gene in normal human keratinocytes. J
Inv Derm 111:1098–1102, 1998
Miyake S, Makimura M, Kanegae Y, et al: Efficient generation of recombinant adenoviruses
using adenovirus DNA-terminal protein complex and a cosmid bearing the full-
length virus genome. Proc Natl Acad Sci USA 93:1320–1324, 1996
Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for
cellular regulation. Nature 334:661–665, 1988
Niwa H, Yamamura K, Miyazaki J: Efficient selection for high-expression transfectants
with a novel eukaryotic vector. Gene 15:193–199, 1991
Ohba M, Ishino K, Kashiwagi M, Kawabe S, Chida K, Huh NH, Kuroki T: Induction
of differentiation in normal human keratinocytes by adenovirus-mediated
introduction of the η and δ isoforms of protein kinase C. Mol Cell Biol 18:5199–
5207, 1998
Ohno S, Konno Y, Akita Y, Yano A, Suzuki K: A point mutation at the putative ATP-
binding site of protein kinase C alpha abolishes the kinase activity and renders it
down-regulation-insensitive. A molecular link between autophosphorylation and
down-regulation. J Biol Chem 265:6296–6300, 1990
Osada S, Mizuno K, Saido TC, Akita Y, Suzuki K, Kuroki T, Ohno S: A phorbol ester
receptor/protein kinase, nPKC η, a new member of the protein kinase C family
predominantly expressed in lung and skin. J Biol Chem 265:22434–22440, 1990
VOL. 4, NO. 2 SEPTEMBER 1999 ADENOVIRUS VECTORS FOR KERATINOCYTES 157
Osada S, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S: A new member of the
protein kinase C family, nPKC θ, predominantly expressed in skeletal muscle. Mol
Cell Biol 12:3930–3938, 1992
Osada S, Hashimoto Y, Nomura S, et al: Predominant expression of nPKCη, a Ca21-
independent isoform of protein kinase C, in epithelial tissues in association with
epithelial differentiation. Cell Growth Differ 4:167–175, 1993
Setoguchi Y, Jaffe HA, Danel C, Crystal RG: Ex vivo and in vivo gene transfer to the
skin using replication-deficient recombinant adenovirus vectors. J Invest Dermatol
102:415–421, 1994
Wigler M, Silverstein S, Lee LS, Pellicer A, Cheng Yc Axel R: Transfer of purified herpes
virus thymidine kinase gene to cultured mouse cell. Cell 11:223–232, 1977
Yuspa SH, Ben T, Hennings H, Lichti U: Divergent responses in epidermal basal cells
exposed to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res
42:2344–2349, 1982
